Lumos Pharma



Ebitda Veränderung Datum
Agenus USD -10.11M 19.02M 2025-03
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Capricor Therapeutics USD -24.58M 17.26M 2025-03
Celldex Therapeutics USD -72.79M 9.81M 2025-09
Cipla INR 12.55B 6.4B 2025-12
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -7.89M 536K 2025-09
CSL USD 1.96B 1.27B 2025-06
Eli Lilly USD 7.88B 378.1M 2025-09
Grifols EUR 482.04M 7.04M 2025-09
Incyte USD 414.5M 92.42M 2025-12
Intrexon USD -24.7M 2.92M 2024-06
Merck USD 8.39B 1.97B 2025-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Pfizer USD 6.08B 351M 2025-09
Prothena USD -39.53M 12.25M 2025-09
Sarepta Therapeutics USD 126.42M 416.82M 2025-06


Lumos Pharma - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.